Safety, pain and function is our proposition
ERT is DM but doesn't provide relief to this extraordinarily debilitating disease.
So as expected PPS is not an aggressive DM drug like for instance Humira, that also has high correlating SAE
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-17
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $153.1K | 752.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 105727 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 143036 | 7 |
View Market Depth
| Last trade - 13.43pm 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |